Tags : Upjohn

Pharma

The European Commission Approves the Merger of Mylan and Upjohn

Shots: The EC has approved the Viatris merger (a merger b/w Upjohn and Mylan) under EU merger regulations but the decision is conditional on the divestment of Mylan’s certain generic therapies EC ensures that the merger does not harm competition and preserves the competitive access to certain genericized therapies for national health services and the […]Read More

Weekly Snapshot

PharmaShots Weekly Snapshot (March 23-27, 2020)

1. Mylan Delays its Merger with Upjohn Due to COVID-19 Pandemic Published: Mar 26, 2020 | Tags: Mylan, Delays, Merger, Upjohn, Due, COVID-19 Pandemic 2.  Medopad Provides its Remote Patient Monitoring Platform to Support Global COVID-19 Pandemic2 Published: Mar 26, 2020 | Tags: Medopad, Provides, Remote Patient Monitoring Platform, Support, Global, COVID-19 Pandemic 3.  Quidel’s […]Read More